Carbomycin is a complex mixture containing carbomycin A with a small portion of carbomycin B. Carbomycin is produced by Streptomyces halstedii and acts as an antibiotic. The drug was approved by FDA under the name Magna-terramycin (in combination with oxytetracycline) for the treatment of bacterial chronic respiratory diseases in chickens. Carbomycin exerts its antibacterial action by binding within the large ribosomal subunit and thus inhibiting the protein synthesis in bacterias.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2363135 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | MAGNA-TERRAMYCIN Approved UseAs an aid in the prevention and treatment of complicated chronic respiratory disease (air-sac infection) caused by Mycoplasma gallisepticum and secondary bacterial organisms associated with chronic respiratory disease such as E. coli. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. | 2014-07 |
|
| Nucleotide sequence analysis of the carbomycin biosynthetic genes including the 3-O-acyltransferase gene from Streptomyces thermotolerans. | 1995-04 |
|
| Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. | 1982-05 |
|
| Cytoplasmic inheritance of erythromycin resistance in human cells. | 1979-09 |
|
| Mutant of Staphylococcus aureus with lincomycin- and carbomycin-inducible resistance to erythromycin. | 1974-05 |
|
| Bacteriophage types and antibiotic sensitivity of staphylococci from bovine milk and human nares. | 1965-09 |
|
| The dried disc technique with bacitracin, carbomycin, erythromycin, polymyxin B, and tetracycline. | 1955-05 |
|
| The treatment of infectious diseases: advances in the use of antimicrobial drugs. | 1953-10 |
Patents
Sample Use Guides
1.0 gram of oxytetracycline as oxytetracycline hydrochloride and 1.0 gram carbomycin as carbomycin base per gallon of drinking water.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 520.1660A
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
||
|
CFR |
21 CFR 556.110
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C166659
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY | |||
|
300000036856
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY | |||
|
3952621T3O
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104385
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY | |||
|
CARBOMYCIN
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY | |||
|
DB11383
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY | |||
|
202
Created by
admin on Mon Mar 31 21:00:02 GMT 2025 , Edited by admin on Mon Mar 31 21:00:02 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
